Sign up
Pharma Capital

Pressure BioSciences expects to win additional patents for its Ultra Sheer Technology pressure-based platform

The UST platform kills bacteria and viruses in milk and other liquids and extends their shelf life
Pressure valve
Pressure BioSciences is collaborating with researchers at Ohio State University to work on this new method of making sure milk and juice are free of pathogens

Richard Schumacher, CEO of Pressure BioSciences Inc (OTCQB:PBIO), expects to win additional patents in the coming months for the company’s pressure-based patented technology platform Ultra Sheer Technology, which gives milk and juice a longer shelf life, according to an interview on Uptick Newswire’s “Stock Day” podcast released Thursday.

The South Easton, Massachusetts, company already holds two patents for Ultra Sheer Technology, which applies high-pressure levels greater than 20,000 pounds per square inch. The technology allows companies to extend the life of milk, and healthier drinks and juices, by reducing heat exposure in the preservation process through a combined application of elevated pressure and controlled times and temperatures.

“So, if there are bacteria or viruses in the liquid food, the UST process will kill these pathogens, bringing their level down to what is known as manufacturing sterile,” Schumacher explained in the interview.

“This will allow the beverage to sit at room temperature storage for extended periods of time (weeks to months), without the need for refrigeration or chemical preservatives,” he added.

Big Picture: Zacks upbeat on Pressure BioSciences' growth potential; targets US$10 a share

Last month, Pressure BioSciences announced that it will be collaborating with researchers at Ohio State University to work on this new method of making sure milk and juice are free of pathogens and chemical preservatives and will not require refrigerated transport. The goal of this working venture will be to bring Ultra Sheer Technology to market.

Read: Ohio State scientists to use Pressure BioSciences's Ultra Shear Technology to sterilize 'clean label' food and drinks

The collaborative project is funded by a US$891,000 grant from the US Department of Agriculture. Ohio State has granted Pressure BioSciences a US$318,000 sub-contract to build a working benchtop instrument and a pilot plant floor model Ultra Shear Technology machine.

Commencing commercial operations in 2007, Pressure BioSciences is a leader in high-pressure-based technologies, platforms and services to the life sciences market worldwide.

Shares in Pressure BioSciences rose nearly 2% to US$3.60 in Thursday's morning session.

Contact Ellen Kelleher at [email protected]

View full PBIO profile View Profile
View All

Related Articles

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.